One of the most important goals for any company is transparent and trustworthy corporate governance. Compliance with laws, guidelines, regulations, ordinances, as well as the internal rules and regulations provides the basis for successful entrepreneurial activity, and constitute a component of good corporate governance.
APONTIS PHARMA's business model is designed for the long term and all measures are geared towards the goal of sustainable positive development. The Executive Board and Supervisory Board identify with the aim of the German Corporate Governance Code to promote good corporate governance oriented towards the benefit of shareholders, employees and customers.
We are committed to building and maintaining a trust-based relationship with our key stakeholders. We provide our shareholders and financial markets with timely, accurate and complete financial information. At APONTIS PHARMA, we continuously work to increase our resilience, because the ability to continue business processes without disruption is critical to our patients, customers and employees. Thus, as a reliable partner to our stakeholders, we strive to ensure long-term value creation in the market.
Contents on this page
Corporate Governance
Good corporate governance determines our actions.
Articles of Association (German only)
Bylaws for the Supervisory Board of APONTIS PHARMA AG (German only)
Declaration of Compliance 2024 (German only)
Declaration of Compliance 2023 (German only)
Declaration of Compliance 2022 (German only)
Declaration of Compliance 2021 (German only)
Whistleblower System
APONTIS PHARMA AG has established a whistleblower system as part of its Code of Conduct. This system is available not only to employees of the company but also to external parties. It provides a secure way to report violations of legal requirements or compliance rules, thereby helping to identify and prevent misconduct. For example, you may report suspected cases of fraud, bribery, violations of antitrust law, or breaches of anti-money laundering regulations. If you have specific and well-founded information regarding legal violations or breaches of internal rules within the APONTIS PHARMA Group, you can contact APONTIS PHARMA AG through our external ombudsman.
APONTIS PHARMA AG has appointed attorney-at-law Stephan Rheinwald as its external ombudsman. Mr. Rheinwald receives reports from employees of the APONTIS PHARMA Group as well as from external parties, such as business partners and customers, regarding suspected criminal offenses or other legal and compliance violations related to the APONTIS PHARMA Group. Submitting a report does not incur any costs or legal fees for the whistleblower. Upon request, the ombudsman will protect the whistleblower's identity to the greatest extent possible. Every report received is treated confidentially and reviewed by specially trained professionals at Compliance Officer Services GmbH.
E-Mail: s.rheinwald@cos-legal.eu
www.cos-gmbh.eu
APONTIS PHARMA AG has appointed attorney-at-law Stephan Rheinwald as its external ombudsman. Mr. Rheinwald receives reports from employees of the APONTIS PHARMA Group as well as from external parties, such as business partners and customers, regarding suspected criminal offenses or other legal and compliance violations related to the APONTIS PHARMA Group. Submitting a report does not incur any costs or legal fees for the whistleblower. Upon request, the ombudsman will protect the whistleblower's identity to the greatest extent possible. Every report received is treated confidentially and reviewed by specially trained professionals at Compliance Officer Services GmbH.
E-Mail: s.rheinwald@cos-legal.eu
www.cos-gmbh.eu
